Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients

Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator

10.1111/1744-9987.13537 ◽

2020 ◽

Vol 24 (5) ◽

pp. 602-606

Author(s):

Shoichiro Daimon

Keyword(s):

Darbepoetin Alfa ◽

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽

Hemoglobin Maintenance and Dosing Strategies Using Intravenous Continuous Erythropoietin Receptor Activator in Japanese Hemodialysis Patients

10.1111/1744-9987.12013 ◽

2013 ◽

pp. n/a-n/a ◽

Cited By ~ 1

Author(s):

Takayuki Hirai ◽

Yoshiko Nishizawa ◽

Hiroshi Nakazono ◽

Mariko Asai ◽

Hideki Yamashita ◽

...

Keyword(s):

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽

Dosing Strategies ◽

Changes in Hepcidin and Reticulocyte Hemoglobin Equivalent Levels in Response to Continuous Erythropoietin Receptor Activator Administration in Hemodialysis Patients: A Randomized Study

10.1111/1744-9987.12161 ◽

2014 ◽

Vol 18 (5) ◽

pp. 421-426 ◽

Cited By ~ 19

Author(s):

Midori Kakimoto-Shino ◽

Yoshiyuki Toya ◽

Tadashi Kuji ◽

Tetsuya Fujikawa ◽

Satoshi Umemura

Keyword(s):

Randomized Study ◽

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽

SP364THE COST-UTILITY OF TREATING ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR OR EPOETIN VERSUS ROUTINE BLOOD TRANSFUSIONS AMONG CHRONIC HEMODIALYSIS PATIENTS

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfy104.sp364 ◽

2018 ◽

Vol 33 (suppl_1) ◽

pp. i468-i468

Author(s):

omar maoujoud

Keyword(s):

Hemodialysis Patients ◽

Cost Utility ◽

Chronic Hemodialysis ◽

Erythropoietin Receptor ◽

Blood Transfusions ◽

Routine Blood ◽

Receptor Activator ◽

Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients

Journal of Pharmacological Sciences ◽

10.1016/j.jphs.2021.05.010 ◽

2021 ◽

Author(s):

Yuki Kawai ◽

Yoshiyuki Toya ◽

Hiromichi Wakui ◽

Tetsuya Fujikawa ◽

Eiko Ueda ◽

...

Keyword(s):

Effective Treatment ◽

Iron Supplementation ◽

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Treatment Interval ◽

Receptor Activator ◽

Monthly Continuous Erythropoietin Receptor Activator Versus Weekly Epoetin-Beta, Similar Hemoglobinization but Different Anisocytosis Degree in Hemodialysis Patients: A Randomized Controlled Trial

Journal of Hematology ◽

10.14740/jh862 ◽

2021 ◽

Vol 10 (6) ◽

pp. 255-265

Author(s):

Miguel G. Uriol-Rivera ◽

Aina Obrador-Mulet ◽

Sonia Jimenez-Mendoza ◽

Antonio Corral-Baez ◽

Leonor Perianez-Parraga ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Randomized Controlled ◽

Epoetin Beta ◽

Receptor Activator ◽

Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients

Renal Replacement Therapy ◽

10.1186/s41100-016-0071-x ◽

2016 ◽

Vol 2 (1) ◽

Cited By ~ 1

Author(s):

Shoichiro Daimon ◽

Hiromi Nuka ◽

Kinya Kitada ◽

Yasunori Suzuki ◽

Fae Kim ◽

...

Keyword(s):

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽

Long-term effect of CERA (continuous erythropoietin receptor activator) administered once every 2 weeks in hemodialysis patients with anemia

Nihon Toseki Igakkai Zasshi ◽

10.4009/jsdt.46.999 ◽

2013 ◽

Vol 46 (10) ◽

pp. 999-1006

Author(s):

Teruhiko Maeba ◽

Ryo Yoshizawa ◽

Shigeru Owada

Keyword(s):

Hemodialysis Patients ◽

Term Effect ◽

Erythropoietin Receptor ◽

Long Term Effect ◽

Receptor Activator ◽

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients

International Journal of Nephrology and Renovascular Disease ◽

10.2147/ijnrd.s96027 ◽

2016 ◽

pp. 35 ◽

Cited By ~ 5

Author(s):

Omar Maoujoud ◽

Samir Ahid ◽

Yahia Cherrah

Keyword(s):

Hemodialysis Patients ◽

Cost Utility ◽

Chronic Hemodialysis ◽

Erythropoietin Receptor ◽

Blood Transfusions ◽

Routine Blood ◽

Receptor Activator ◽

Continuous Erythropoietin Receptor Activator ◽

The Cost

Comparison of the Effect of the Same Dose of a 4-Weekly Continuous Erythropoietin Receptor Activator Administered Once Every 2 or 4 Weeks in Hemodialysis Patients

10.1111/1744-9987.12200 ◽

2014 ◽

Vol 18 (5) ◽

pp. 518-520 ◽

Cited By ~ 1

Author(s):

Shoichiro Daimon

Keyword(s):

Hemodialysis Patients ◽

Erythropoietin Receptor ◽

Receptor Activator ◽